Ultima-Cyp 250 Ultima Pharmaceuticals: Compound Profile
Ultima-Cyp 250 is a testosterone cypionate formulation developed by Ultima Pharmaceuticals for advanced laboratory research applications. This long-acting testosterone ester represents a cornerstone compound in androgen receptor studies, offering researchers a stable platform to investigate testosterone’s molecular mechanisms. Research scientists at Stroid UK Shop utilise this compound to examine androgenic and anabolic pathways in controlled laboratory environments.
Laboratory Applications
This testosterone cypionate preparation enables comprehensive research into steroid hormone biology and receptor pharmacology. Laboratory studies examine testosterone’s effects on protein synthesis pathways, nitrogen retention mechanisms, and cellular anabolic processes. Research applications include investigating androgen receptor binding kinetics, examining dose-response relationships in tissue culture systems, and analysing metabolic pathway modulation. Scientists studying testosterone cypionate formulations appreciate the compound’s extended half-life characteristics for sustained research protocols. Comparative studies alongside selective androgen receptor modulators and research peptides provide valuable insights into different androgenic mechanisms.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Testosterone Cypionate |
| Concentration | 250mg/ml |
| Manufacturer | Ultima Pharmaceuticals |
| Product Code | EU20834 |
| Storage Requirements | Room temperature, protected from light |
| Molecular Formula | C₂₇H₄₀O₃ |
| CAS Number | 58-20-8 |
| Half-life | 8-12 days (research models) |
Research Compliance Statement
Ultima-Cyp 250 is manufactured exclusively for in-vitro research purposes and laboratory studies. This compound is not intended for human consumption, therapeutic use, or any application outside of controlled scientific environments. Research institutions must ensure proper handling protocols, waste disposal procedures, and regulatory compliance when conducting studies with this testosterone cypionate formulation. All research applications should follow established laboratory safety guidelines and institutional review protocols.
